A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes
(2002) In Human Genetics 110(2). p.111-121- Abstract
- Chromosomal region 13q21-q22 harbors a putative breast cancer susceptibility gene and has been implicated as a common site for somatic deletions in a variety of malignant tumors. We have built a complete physical clone contig for a region between D13S1308 and AFM220YE9 based on 18 yeast artificial chromosome and 81 bacterial artificial chromosome (BAC) clones linked together by 22 genetic markers and 61 other sequence tagged sites. Combining data from 47 sequenced BACs (as of June 2001), we have assembled in silico an integrated 5.7-Mb genomic map with 90% sequence coverage. This area contains eight known genes, two hypothetical proteins, 24 additional Unigene clusters, and approximately 100 predicted genes and exons. We have determined... (More)
- Chromosomal region 13q21-q22 harbors a putative breast cancer susceptibility gene and has been implicated as a common site for somatic deletions in a variety of malignant tumors. We have built a complete physical clone contig for a region between D13S1308 and AFM220YE9 based on 18 yeast artificial chromosome and 81 bacterial artificial chromosome (BAC) clones linked together by 22 genetic markers and 61 other sequence tagged sites. Combining data from 47 sequenced BACs (as of June 2001), we have assembled in silico an integrated 5.7-Mb genomic map with 90% sequence coverage. This area contains eight known genes, two hypothetical proteins, 24 additional Unigene clusters, and approximately 100 predicted genes and exons. We have determined the cDNA and genomic sequence, and tissue expression profiles for the KIAA1008 protein (homologous to the yeast mitotic control protein dis3+), KLF12 (AP-2 repressor), progesterone induced blocking factor 1, zinc finger transcription factor KLF5, and LIM domain only-7, and for the hypothetical proteins FLJ22624 and FLJ21869. Mutation screening of the five known genes in 19 breast cancer families has revealed numerous polymorphisms, but no deleterious mutations. These data provide a basis and resources for further analyses of this chromosomal region in the development of cancer. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/341108
- author
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Human Genetics
- volume
- 110
- issue
- 2
- pages
- 111 - 121
- publisher
- Springer
- external identifiers
-
- wos:000174691800001
- pmid:11935316
- scopus:0036487997
- ISSN
- 1432-1203
- DOI
- 10.1007/s00439-001-0646-6
- language
- English
- LU publication?
- yes
- id
- 544cc04a-1060-45ed-932c-3d3d1ab30579 (old id 341108)
- date added to LUP
- 2016-04-01 16:39:02
- date last changed
- 2022-01-28 21:06:53
@article{544cc04a-1060-45ed-932c-3d3d1ab30579, abstract = {{Chromosomal region 13q21-q22 harbors a putative breast cancer susceptibility gene and has been implicated as a common site for somatic deletions in a variety of malignant tumors. We have built a complete physical clone contig for a region between D13S1308 and AFM220YE9 based on 18 yeast artificial chromosome and 81 bacterial artificial chromosome (BAC) clones linked together by 22 genetic markers and 61 other sequence tagged sites. Combining data from 47 sequenced BACs (as of June 2001), we have assembled in silico an integrated 5.7-Mb genomic map with 90% sequence coverage. This area contains eight known genes, two hypothetical proteins, 24 additional Unigene clusters, and approximately 100 predicted genes and exons. We have determined the cDNA and genomic sequence, and tissue expression profiles for the KIAA1008 protein (homologous to the yeast mitotic control protein dis3+), KLF12 (AP-2 repressor), progesterone induced blocking factor 1, zinc finger transcription factor KLF5, and LIM domain only-7, and for the hypothetical proteins FLJ22624 and FLJ21869. Mutation screening of the five known genes in 19 breast cancer families has revealed numerous polymorphisms, but no deleterious mutations. These data provide a basis and resources for further analyses of this chromosomal region in the development of cancer.}}, author = {{Rozenblum, E and Vahteristo, P and Törngren, Therese and Bergthorsson, JT and Syrjakoski, K and Weaver, D and Haraldsson, Karin and Johannsdottir, HK and Vehmanen, P and Nigam, S and Golberger, N and Robbins, C and Pak, E and Dutra, A and Gillander, E and Stephan, DA and Bailey-Wilson, J and Juo, SHH and Kainu, T and Arason, A and Barkardottir, RB and Nevanlinna, H and Borg, Åke and Kallioniemi, OP}}, issn = {{1432-1203}}, language = {{eng}}, number = {{2}}, pages = {{111--121}}, publisher = {{Springer}}, series = {{Human Genetics}}, title = {{A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes}}, url = {{http://dx.doi.org/10.1007/s00439-001-0646-6}}, doi = {{10.1007/s00439-001-0646-6}}, volume = {{110}}, year = {{2002}}, }